Of mice and men: On the origin of XMRV

Frontiers in Microbiology

Volumn 1, Issue JAN, 2011, Pages

  van der Kuyl, Antoinette Cornelia ^a   Cornelissen, Marion ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Mouse; Retrovirus; Transmission; Vaccine; XMRV

Indexed keywords

EID: 79955068133     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2010.00147     Document Type: Article

References (74)

1. Amit, M., Winkler, M. E., Menke, S., Bruning, E., Buscher, K., Denner, J., Haverich, A., Itskovitz-Eldor, J., and Martin, U. (2005). No evidence for infection of human embryonic stem cells by feeder cell-derived murine leukemia viruses. Stem Cells 23, 761-771.
2. Arnold, R. S., Makarova, N. V., Osunkoya, A. O., Suppiah, S., Scott, T. A., Johnson, N. A., Bhosle, S. M., Liotta, D., Hunter, E., Marshall, F. F., Ly, H., Molinaro, R. J., Blackwell, J. L., and Petros, J. A. (2010). XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 75, 755-761.
3. Baliji, S., Liu, Q., and Kozak, C. A. (2010). Common inbred strains of the laboratory mouse that are susceptible to infection by mouse xenotropic Gammaretroviruses and the human derived XMRV. J. Virol. 84, 12841-12849.
4. Barnes, E., Flanagan, P., Brown, A., Robinson, N., Brown, H., McClure, M., Oxenius, A., Collier, J., Weber, J., Günthard, H. F., Hirschel, B., Fidler, S., Phillips, R., and Frater, J. (2010). Failure to detect xenotropic murine leukemia virus related virus in blood of individuals at high risk of blood borne viral infections. J. Infect. Dis. 202, 1482-1485.
5. Battini, J. L., Rasko, J. E., and Miller, A. D. (1999). A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proc Natl. Acad. Sci. U.S.A. 96, 1385-1390.
6. Calattini, S., Wanert, F., Thierry, B., Schmitt, C., Bassot, S., Saib, A., Herrenschmidt, N., and Gessain, A. (2006). Modes of transmission and genetic diversity of foamy viruses in a Macaca tonkeana colony. Retrovirology 3, 23.
7. Charrel, R. N., and de Lamballerie, X. (2010). Zoonotic aspects of Arenavirus infections. Vet. Microbiol. 140, 213-220.
8. Coffin, J. M., and Stoye, J. P. (2009). Virology. A new virus for old diseases? Science 326, 530-531.
9. Cornelissen, M., Zorgdrager, F., Blom, P., Jurriaans, S., Repping, S., van, L. E., Bakker, M., Berkhout, B., and van der Kuyl, A. C. (2010). Lack of detection of XMRV in seminal plasma from HIV-1 infected men in The Netherlands. PLoS ONE, 5, e12040. doi: 10.1371/ journal.pone.0012040
10. Courgnaud, V., Battini, J. L., Sitbon, M., and Mason, A. L. (2010). Mouse retroviruses and chronic fatigue syndrome: does X (or P) mark the spot? Proc. Natl. Acad. Sci. U.S.A. 107, 15666-15667.
11. Danielson, B. P., Ayala, G. E., and Kimata, J. T. (2010). Detection of xenotropic murine leukemia virus related virus in normal and tumor tissue of patients from the Southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J. Infect. Dis. 202, 1470-1477.
12. Dennehy, P. H. (2001). Active immunization in the United States: developments over the past decade. Clin. Microbiol. Rev. 14, 872-908.
13. Dong, B., Kim, S., Hong, S., Das, G. J., Malathi, K., Klein, E. A., Ganem, D., DeRisi, J. L., Chow, S. A., and Silverman, R. H. (2007). An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc. Natl. Acad. Sci. U. S. A. 104, 1655-1660.
14. Erlwein, O., Kaye, S., Robinson, M., and McClure, M. (2010a). Chronic fatigue syndrome: xenotropic murine leukemia virus-related virus, murine leukemia virus, both, or neither? Proc. Natl. Acad. Sci. U.S.A. 107, E161.
15. Erlwein, O., Kaye, S., McClure, M. O., Weber, J., Wills, G., Collier, D., Wessely, S., and Cleare, A. (2010b). Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS ONE 5, e8519. doi: 10.1371/journal. pone.0008519
16. Evans, L. H., Alamgir, A. S., Owens, N., Weber, N., Virtaneva, K., Barbian, K., Babar, A., Malik, F., and Rosenke, K. (2009). Mobilization of endogenous retroviruses in mice after infection with an exogenous retrovirus. J. Virol. 83, 2429-2435.
17. Fischer, N., Hellwinkel, O., Schulz, C., Chun, F. K., Huland, H., Aepfelbacher, M., and Schlomm, T. (2008). Prevalence of human Gammaretrovirus XMRV in sporadic prostate cancer. J. Clin. Virol. 43, 277-283.
18. Fischer, N., Schulz, C., Stieler, K., Hohn, O., Lange, C., Drosten, C., and Aepfelbacher, M. (2010). Xenotropic murine leukemia virus-related Gammaretrovirus in respiratory tract. Emerging Infect. Dis. 16, 1000-1002.
19. Fletcher, M. A., Hessel, L., and Plotkin, S. A. (1998). Human diploid cell strains (HDCS) viral vaccines. Dev. Biol. Stand. 93, 97-107.
20. Frierson, J. G. (2010). The yellow fever vaccine: a history. Yale J. Biol. Med. 83, 77-85.
21. Grabenstein, J. D., and Winkenwerder, W. Jr. (2003). US military smallpox vaccination program experience. JAMA 289, 3278-3282.
22. Groom, H. C., Yap, M. W., Galao, R. P., Neil, S. J., and Bishop, K. N. (2010). Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc. Natl. Acad. Sci. U.S.A. 107, 5166-5177.
23. Hart, C. A., and Bennett, M. (1999). Hantavirus infections: epidemiology and pathogenesis. Microbes Infect. 1, 1229-1237.
24. Hartley, J. W., Evans, L. H., Green, K. Y., Naghashfar, Z., Macias, A. R., Zerfas, P. M., and Ward, J. M. (2008). Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line. Retrovirology 5, 1.
25. Henrich, T. J., Li, J. Z., Felsenstein, D., Kotton, C. N., Plenge, R. M., Pereyra, F., Marty, F. M., Lin, N. H., Grazioso, P., Crochiere, D. M., Eggers, D., Kuritzkes, D. R., and Tsibris, A. M. N. (2010). Xenotropic murine leukemia virus related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. J. Infect. Dis. 202, 1478-1481.
26. Hong, P., Li, J., and Li, Y. (2010). Failure to detect xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol. J. 7, 224.
27. Hong, S., Klein, E. A., Das, G. J., Hanke, K., Weight, C. J., Nguyen, C., Gaughan, C., Kim, K. A., Bannert, N., Kirchhoff, F., Munch, J., and Silverman, R. H. (2009). Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J. Virol. 83, 6995-7003.
28. Hussain, A. I., Johnson, J. A., Da Silva, F. M., and Heneine, W. (2003). Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: investigation of transmission to vaccine recipients. J. Virol. 77, 1105-1111.
29. Inactivated Japanese Encephalitis Virus Vaccine. (1993). Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 42, 1-15.
30. Jeziorski, E., Foulongne, V., Ludwig, C., Louhaem, D., Chiocchia, G., Segondy, M., Rodiere, M., Sitbon, M., and Courgnaud, V. (2010). No evidence for XMRV association in pediatric idiopathic diseases in France. Retrovirology 7, 63.
31. Kaiser, J. (2010). Virology. No meeting of minds on XMRV's role in chronic fatigue, cancer. Science 329, 1454.
32. Kearney, M., and Maldarelli, F. (2010). Current status of xenotropic murine leukemia virus-related retrovirus in chronic fatigue syndrome and prostate cancer: reach for a scorecard, not a prescription pad. J. Infect. Dis. 202, 1463-1466.
33. Kim, S., Kim, N., Dong, B., Boren, D., Lee, S. A., Das, G. J., Gaughan, C., Klein, E. A., Lee, C., Silverman, R. H., and Chow, S. A. (2008). Integration site preference of xenotropic murine leukemia virusrelated virus, a new human retrovirus associated with prostate cancer. J. Virol. 82, 9964-9977.
34. Klein, S. L., and Calisher, C. H. (2007). Emergence and persistence of Hantaviruses. Curr. Top. Microbiol. Immunol. 315, 217-252.
35. Knouf, E. C., Metzger, M. J., Mitchell, P. S., Arroyo, J. D., Chevillet, J. R., Tewari, M., and Miller, A. D. (2009). Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J. Virol. 83, 7353-7356.
36. Kohler, G., and Milstein, C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497.
37. Kunstman, K. J., Bhattacharya, T., Flaherty, J., Phair, J. P., and Wolinsky, S. M. (2010). Absence of xenotropic murine leukemia virus-related virus in blood cells of men at risk for and infected with HIV. AIDS 24, 1784-1785.
38. Kwon, D. N., Nguyen, S., Chew, A., Hsu, K., Greenhalgh, D., and Cho, K. (2008). Identification of putative endogenous retroviruses actively transcribed in the brain. Virus Genes 36, 439-447.
39. Liu, W., Worobey, M., Li, Y., Keele, B. F., Bibollet-Ruche, F., Guo, Y., Goepfert, P. A., Santiago, M. L., Ndjango, J. B., Neel, C., Clifford, S. L., Sanz, C., Kamenya, S., Wilson, M. L., Pusey, A. E., GrossCamp, N., Boesch, C., Smith, V., Zamma, K., Huffman, M. A., Mitani, J. C., Watts, D. P., Peeters, M., Shaw, G. M., Switzer, W. M., Sharp, P. M., and Hahn, B. H. (2008). Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees. PLoS Pathog. 4, e1000097. doi: 10.1371/journal.ppat.1000097
40. Lo, S. C., Pripuzova, N., Li, B., Komaroff, A. L., Hung, G. C., Wang, R., and Alter, H. J. (2010). Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc. Natl. Acad. Sci. U.S.A. 107, 15874-15879.
41. Lombardi, V. C., Ruscetti, F. W., Das, G. J., Pfost, M. A., Hagen, K. S., Peterson, D. L., Ruscetti, S. K., Bagni, R. K., Petrow-Sadowski, C., Gold, B., Dean, M., Silverman, R. H., and Mikovits, J. A. (2009). Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326, 585-589.
42. Maric, R., Pedersen, F. S., Kjeldbjerg, A., Moeller-Larsen, A., Bahrami, S., Brudek, T., Petersen, T., and Christensen, T. (2010). Absence of xenotropic murine leukaemia virusrelated virus in Danish patients with multiple sclerosis. J. Clin. Virol. 49, 227-228.
43. Marin, M., Tailor, C. S., Nouri, A., Kozak, S. L., and Kabat, D. (1999). Polymorphisms of the cell surface receptor control mouse susceptibilities to xenotropic and polytropic leukemia viruses. J. Virol. 73, 9362-9368.
44. Martinez-Fierro, M. L., Leach, R. J., Gomez-Guerra, L. S., GarzaGuajardo, R., Johnson-Pais, T., Beuten, J., Morales-Rodriguez, I. B., Hernandez-Ordonez, M. A., Calderon-Cardenas, G., OrtizLopez, R., Rivas-Estilla, A. M., Ncer-Rodriguez, J., and Rojas-Martinez, A. (2010). Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer 10, 326. doi: 10.1186/14712407-10-326
45. Miyazawa, T. (2010). Endogenous retroviruses as potential hazards for vaccines. Biologicals 38, 371-376.
46. Miyazawa, T., Yoshikawa, R., Golder, M., Okada, M., Stewart, H., and Palmarini, M. (2010). Isolation of an infectious endogenous retrovirus in a proportion of live attenuated vaccines for pets. J. Virol. 84, 3690-3694.
47. Murray, R. (1964). Biologicals for the control and therapy of virus diseases. Bacteriol. Rev. 28, 493-496.
48. Paprotka, T., Venkatachari, N. J., Chaipan, C., Burdick, R., Delviks-Frankenberry, K. A., Hu, W. S., and Pathak, V. K. (2010). Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J. Virol. 84, 5719-5729.
49. Pastoret, P. P. (2010). Human and animal vaccine contaminations. Biologicals 38, 332-334.
50. Plotkin, S. A., and Wiktor, T. (1978). Rabies vaccination. Annu. Rev. Med. 29, 583-591.
51. Portis, J. L., McAtee, F. J., and Hayes, S. F. (1987). Horizontal transmission of murine retroviruses. J. Virol. 61, 1037-1044.
52. Ribet, D., Harper, F., Esnault, C., Pierron, G., and Heidmann, T. (2008). The GLN family of murine endogenous retroviruses contains an element competent for infectious viral particle formation. J. Virol. 82, 4413-4419.
53. Sanjuan, R., Nebot, M. R., Chirico, N., Mansky, L. M., and Belshaw, R. (2010). Viral mutation rates. J. Virol. 84, 9733-9748.
54. Satterfield, B. C., Garcia, R. A., Gurrieri, F., and Schwartz, C. E. (2010). PCR and serology find no association between xenotropic murine leukemia virusrelated virus (XMRV) and autism. Mol. Autism 1, 14.
55. Sfanos, K. S., Sauvageot, J., Fedor, H. L., Dick, J. D., De Marzo, A. M., and Isaacs, W. B. (2008). A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 68, 306-320.
56. Sharma, P., Suppiah, S., Molinaro, R., Rogers, K., Das Gupta, J., Silverman, R., Hackett, J. Jr., Devare, S., Schochetman, G., and Villinger, F. (2010). "Organ and cell lineage dissemination of XMRV in rhesus macaques during acute and chronic infection [abstract]," in CROI, San Francisco, February 16-19, 2010, Paper #150LB.
57. Silverman, R. H., Nguyen, C., Weight, C. J., and Klein, E. A. (2010). The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome. Nat. Rev. Urol. 7, 392-402.
58. Sramkoski, R. M., Pretlow, T. G., Giaconia, J. M., Pretlow, T. P., Schwartz, S., Sy, M. S., Marengo, S. R., Rhim, J. S., Zhang, D., and Jacobberger, J. W. (1999). A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell. Dev. Biol. Anim. 35, 403-409.
59. Stang, A., Petrasch-Parwez, E., Brandt, S., Dermietzel, R., Meyer, H. E., Stuhler, K., Liffers, S. T., Uberla, K., and Grunwald, T. (2009). Unintended spread of a biosafety level 2 recombinant retrovirus. Retrovirology 6, 86.
60. Stern, M., and Herrmann, R. (2005). Overview of monoclonal antibodies in cancer therapy: present and promise. Crit. Rev. Oncol. Hematol. 54, 11-29.
61. Stieler, K., Schulz, C., Lavanya, M., Aepfelbacher, M., Stocking, C., and Fischer, N. (2010). Host range and cellular tropism of the human exogenous Gammaretrovirus XMRV. Virology 399, 23-30.
62. Switzer, W. M., Bhullar, V., Shanmugam, V., Cong, M. E., Parekh, B., Lerche, N. W., Yee, J. L., Ely, J. J., Boneva, R., Chapman, L. E., Folks, T. M., and Heneine, W. (2004). Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J. Virol. 78, 2780-2789.
63. Switzer, W. M., Jia, H., Hohn, O., Zheng, H., Tang, S., Shankar, A., Bannert, N., Simmons, G., Hendry, R. M., Falkenberg, V. R., Reeves, W. C., and Heneine, W. (2010). Absence of evidence of xenotropic murine leukemia Virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology 7, 57.
64. Tailor, C. S., Nouri, A., Lee, C. G., Kozak, C., and Kabat, D. (1999). Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc. Natl. Acad. Sci. U.S.A. 96, 927-932.
65. Takeuchi, Y., McClure, M. O., and Pizzato, M. (2008). Identification of Gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J. Virol. 82, 12585-12588.
66. Trijzelaar, B. (1993). Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice-validation of virus removal and inactivation. Biotherapy 6, 93-102.
67. Urisman, A., Molinaro, R. J., Fischer, N., Plummer, S. J., Casey, G., Klein, E. A., Malathi, K., Magi-Galluzzi, C., Tubbs, R. R., Ganem, D., Silverman, R. H., and DeRisi, J. L. (2006). Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2, e25. doi: 10.1371/journal. ppat.0020025
68. van der Kuyl, A. C., Dekker, J. T., and Goudsmit, J. (1999). Discovery of a new endogenous type C retrovirus (FcEV) in cats: evidence for RD-114 being an FcEV(Gag-Pol)/baboon endogenous virus BaEV(Env) recombinant. J. Virol. 73, 7994-8002.
69. van Kuppeveld, F. J., De Jong, A. S., Lanke, K. H., Verhaegh, G. W., Melchers, W. J., Swanink, C. M., Bleijenberg, G., Netea, M. G., Galama, J. M., and van der Meer, J. W. (2010). Prevalence of xenotropic murine leukaemia virusrelated virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 340, c1018.
70. Verhaegh, G. W., De Jong, A. S., Smit, F. P., Jannink, S. A., Melchers, W. J., and Schalken, J. A. (2010). Prevalence of human xenotropic murine leukemia virus-related Gammaretrovirus (XMRV) in dutch prostate cancer patients. Prostate PMID: 20878949. [Epub ahead of print].
71. Weiss, R. A. (2010). A cautionary tale of virus and disease. BMC Biol. 8, 124. doi: 10.1186/1741-7007-8-124
72. Yan, Y., Liu, Q., Wollenberg, K., Martin, C., Buckler-White, A., and Kozak, C. A. (2010). Evolution of functional and sequence variants of the mammalian XPR1 receptor for mouse xenotropic Gammaretroviruses and the human-derived XMRV. J. Virol. 84, 11970-11980.
73. Yang, H., Bell, T. A., Churchill, G. A., and De Villena, F. P.-M. (2007). On the subspecific origin of the laboratory mouse. Nat. Genet. 39, 1100-1107.
74. Yoshikawa, R., Sato, E., Igarashi, T., and Miyazawa, T. (2010). Characterization of RD-114 virus isolated from a commercial canine vaccine manufactured using CRFK cells. J. Clin. Microbiol. 48, 3366-3369.